Shu-Yang Li

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Escherichia Coli

Kidney Transplantation

Dendritic Cells

High Performance Liquid Chromatography

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Masaaki Ito, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Hirotaka Takizawa, Shu-Yang Li, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Takaki Hiwasa, Hideaki Shimada
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma. Cancer science 115 (7) (2024)
Masaaki Ito, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Hirotaka Takizawa, Shu-Yang Li, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Takaki Hiwasa, Hideaki Shimada
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma. Cancer science (2024)
Masaaki Ito, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Hirotaka Takizawa, Shu-Yang Li, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Takaki Hiwasa, Hideaki Shimada
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma. Cancer science 115 (7) (2024)
Masaaki Ito, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Hirotaka Takizawa, Shu-Yang Li, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Takaki Hiwasa, Hideaki Shimada
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma. Cancer science 115 (7) (2024)
Masaaki Ito, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Hirotaka Takizawa, Shu-Yang Li, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Takaki Hiwasa, Hideaki Shimada
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma. Cancer science 115 (7) (2024)
Masaaki Ito, Satoshi Yajima, Takashi Suzuki, Yoko Oshima, Tatsuki Nanami, Makoto Sumazaki, Fumiaki Shiratori, Hirotaka Takizawa, Shu-Yang Li, Bo-Shi Zhang, Yoichi Yoshida, Tomoo Matsutani, Takaki Hiwasa, Hideaki Shimada
Combination of high anti-SKI and low anti-TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma. Cancer science 115 (7) (2024)